Fentanyl Contamination of Stimulant Drugs

Community-based drug checking provides the most granular picture of real-world contamination rates. A major study published in Drug and Alcohol Dependence in 2023 analyzed 718 confirmed stimulant samples submitted by 77 harm reduction programs across 25 U.S. states from May 2021 to June 2023. The results showed that fentanyl was present in 12.5 percent of powder methamphetamine samples and 14.8 percent of powder cocaine samples.

People who primarily use stimulants are uniquely vulnerable to fentanyl exposure for several overlapping reasons. First and most critically, most stimulant users have no opioid tolerance. A dose of fentanyl that might produce manageable sedation in someone with regular opioid exposure can cause fatal respiratory depression in an opioid-naive person. Fentanyl is 50 to 100 times more potent than morphine, and a lethal dose can be as small as two milligrams, equivalent to a few grains of salt.

While laboratory drug checking has found that crack cocaine in rock form is less commonly contaminated with fentanyl than powder cocaine, documented overdose clusters demonstrate that the risk is real and potentially catastrophic. In July 2016, a batch of crack cocaine adulterated with furanyl-fentanyl caused a spike of overdose events in British Columbia, Canada. Of the patients who presented, 51 percent lost consciousness after smoking what they believed was crack cocaine. In Philadelphia, 18 patients who had not used opioids presented over a four-day period with severe opioid intoxication after smoking crack cocaine contaminated with fentanyl; three of those patients died.

Not all stimulant-opioid co-exposure is accidental. The intentional combination of opioids with stimulants has a long history and is now surging alongside the fentanyl crisis. A "speedball" traditionally refers to heroin combined with cocaine, while a "goofball" describes heroin mixed with methamphetamine. In the fentanyl era, these combinations increasingly involve illicitly manufactured fentanyl rather than heroin, creating what some researchers call a "super goofball." According to data cited by Ciccarone (2024), 60 percent of fentanyl-positive drug tests in 2023 also contained methamphetamine, an 875 percent increase in co-use since 2015.

When a person is exposed to both a stimulant and fentanyl, the clinical presentation can differ significantly from a straightforward opioid overdose, complicating diagnosis and treatment in emergency settings. The opposing pharmacological effects of stimulants and opioids can mask one another, making it harder for first responders and emergency physicians to identify the overdose type quickly. Data from the American College of Medical Toxicology shows that coma or central nervous system depression was present in 62.5 percent of opioid-only overdose consultations but in only 50 percent of opioid-and-cocaine cases and 46.5 percent of opioid-and-methamphetamine cases, suggesting that the stimulant partially counteracts the sedative effects of the opioid. This masking can delay the administration of naloxone because the patient may not appear to be in a classic opioid overdose.

A growing body of evidence demonstrates that stimulant users who adopt drug checking practices do change their behavior in meaningful, protective ways. The JAMA Network Open study found that people who used FTS were significantly more likely to take a smaller test dose, use with someone else present, keep naloxone accessible, and slow down their consumption when fentanyl was detected. Among stimulant users specifically, qualitative research found that a positive fentanyl result prompted users to discard the drug, seek a different source, use a smaller amount, or switch their route of administration to one perceived as lower risk. Drug checking also drove peer-to-peer information sharing: when a user detected fentanyl in their cocaine or methamphetamine, they frequently warned others in their network, creating a community-level early warning system.

Given the reality that any stimulant powder or pill purchased outside a pharmacy may contain fentanyl, a full harm reduction approach for stimulant users should include multiple layers of protection. First, test before you use. Fentanyl test strips work on cocaine, methamphetamine, crushed pills, and other stimulant forms. Dissolving a small sample in the appropriate amount of water and dipping a strip takes under five minutes and can reveal an otherwise invisible threat.

The fentanyl contamination of stimulant drugs is not a static problem. As the illicit drug market evolves, so do the risks. The emergence of xylazine (a veterinary tranquilizer) as an adulterant in both opioid and stimulant supplies adds another layer of complexity, as xylazine is not reversed by naloxone and can cause severe skin wounds. Nitazenes, a class of synthetic opioids even more potent than fentanyl, have been detected in some drug markets.